Iron content of glioblastoma tumours and role of ferrous iron in the hypoxic response in vitro

IntroductionGlioblastomas are an aggressive primary brain cancer, characterised by hypoxia and poor patient survival. Iron is the most abundant transition metal in the brain, yet data on the iron content of brain cancers is sparse. Ferrous iron is an essential cofactor for a super-family of enzymes,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Praditi, Citra (VerfasserIn) , Beverley-Stone, Eira (VerfasserIn) , Reid, Malcolm (VerfasserIn) , Burgess, Eleanor R. (VerfasserIn) , Crake, Rebekah L. (VerfasserIn) , Vissers, Margreet C. M. (VerfasserIn) , Royds, Janice A. (VerfasserIn) , Slatter, Tania L. (VerfasserIn) , Dachs, Gabi U. (VerfasserIn) , Phillips, Elisabeth (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 07 March 2025
In: Frontiers in oncology
Year: 2025, Jahrgang: 15, Pages: 1-12
ISSN:2234-943X
DOI:10.3389/fonc.2025.1536549
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fonc.2025.1536549
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1536549/full
Volltext
Verfasserangaben:Citra Praditi, Eira Beverley-Stone, Malcolm Reid, Eleanor R. Burgess, Rebekah L. Crake, Margreet C. M. Vissers, Janice A. Royds, Tania L. Slatter, Gabi U. Dachs and Elisabeth Phillips

MARC

LEADER 00000naa a2200000 c 4500
001 1929682530
003 DE-627
005 20250703114342.0
007 cr uuu---uuuuu
008 250703s2025 xx |||||o 00| ||eng c
024 7 |a 10.3389/fonc.2025.1536549  |2 doi 
035 |a (DE-627)1929682530 
035 |a (DE-599)KXP1929682530 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Praditi, Citra  |e VerfasserIn  |0 (DE-588)1370511353  |0 (DE-627)1929682743  |4 aut 
245 1 0 |a Iron content of glioblastoma tumours and role of ferrous iron in the hypoxic response in vitro  |c Citra Praditi, Eira Beverley-Stone, Malcolm Reid, Eleanor R. Burgess, Rebekah L. Crake, Margreet C. M. Vissers, Janice A. Royds, Tania L. Slatter, Gabi U. Dachs and Elisabeth Phillips 
264 1 |c 07 March 2025 
300 |b Illustrationen 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.07.2025 
520 |a IntroductionGlioblastomas are an aggressive primary brain cancer, characterised by hypoxia and poor patient survival. Iron is the most abundant transition metal in the brain, yet data on the iron content of brain cancers is sparse. Ferrous iron is an essential cofactor for a super-family of enzymes, the iron- and 2-oxoglutarate-dependent dioxygenase enzymes (2-OGDD). These enzymes control the response to hypoxia via hydroxylation of the hypoxia-inducible factor-1α (HIF-1α), and DNA demethylation via hydroxylation of 5-methyl cytosines (5hmC).MethodsThis study used clinical glioblastoma samples from 40 patients to determine the relationship between 2-OGDD activity and iron. Elemental iron was measured using inductively coupled plasma mass spectrometry (ICP-MS) and ferrous iron was measured using the colorimetric ferrozine assay. Iron measurements were compared against patient survival and clinicopathological data, and 2-OGDD-dependent activity of HIF-1 activation and 5hmC.Results and discussionElemental and ferrous iron levels were weakly related. Higher ferrous iron content of clinical glioblastoma tissue was associated with longer overall survival compared to lower ferrous iron content, but elemental iron showed no such relationship. Neither form of iron was related to clinicopathological data or markers of 2-OGDD activity. The impact of iron supplementation on the hypoxic response was assessed in three glioblastoma cell lines in vitro, similarly showing only a limited influence of iron on these 2-OGDD enzymes. Our data, together with prior studies in anaemic patients, highlight the importance of healthy iron levels in patients with glioblastoma, but further mechanistic studies are needed to elucidate the molecular pathways involved. 
650 4 |a brain cancer 
650 4 |a elemental iron 
650 4 |a ferrous iron 
650 4 |a glioblastoma 
650 4 |a hypoxia 
650 4 |a survival 
700 1 |a Beverley-Stone, Eira  |e VerfasserIn  |4 aut 
700 1 |a Reid, Malcolm  |e VerfasserIn  |4 aut 
700 1 |a Burgess, Eleanor R.  |d 1995-  |e VerfasserIn  |0 (DE-588)1352718693  |0 (DE-627)1913624072  |4 aut 
700 1 |a Crake, Rebekah L.  |e VerfasserIn  |4 aut 
700 1 |a Vissers, Margreet C. M.  |e VerfasserIn  |4 aut 
700 1 |a Royds, Janice A.  |e VerfasserIn  |4 aut 
700 1 |a Slatter, Tania L.  |e VerfasserIn  |4 aut 
700 1 |a Dachs, Gabi U.  |e VerfasserIn  |4 aut 
700 1 |a Phillips, Elisabeth  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in oncology  |d Lausanne : Frontiers Media, 2011  |g 15(2025), Seite 1-12  |h Online-Ressource  |w (DE-627)684965518  |w (DE-600)2649216-7  |w (DE-576)35841184X  |x 2234-943X  |7 nnas  |a Iron content of glioblastoma tumours and role of ferrous iron in the hypoxic response in vitro 
773 1 8 |g volume:15  |g year:2025  |g pages:1-12  |g extent:12  |a Iron content of glioblastoma tumours and role of ferrous iron in the hypoxic response in vitro 
856 4 0 |u https://doi.org/10.3389/fonc.2025.1536549  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1536549/full  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250703 
993 |a Article 
994 |a 2025 
998 |g 1352718693  |a Burgess, Eleanor R.  |m 1352718693:Burgess, Eleanor R.  |d 60000  |e 60000PB1352718693  |k 0/60000/  |p 4 
999 |a KXP-PPN1929682530  |e 4741960242 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 03.07.2025"],"language":["eng"],"recId":"1929682530","person":[{"roleDisplay":"VerfasserIn","display":"Praditi, Citra","role":"aut","family":"Praditi","given":"Citra"},{"family":"Beverley-Stone","given":"Eira","roleDisplay":"VerfasserIn","display":"Beverley-Stone, Eira","role":"aut"},{"family":"Reid","given":"Malcolm","roleDisplay":"VerfasserIn","display":"Reid, Malcolm","role":"aut"},{"given":"Eleanor R.","family":"Burgess","role":"aut","roleDisplay":"VerfasserIn","display":"Burgess, Eleanor R."},{"given":"Rebekah L.","family":"Crake","role":"aut","display":"Crake, Rebekah L.","roleDisplay":"VerfasserIn"},{"family":"Vissers","given":"Margreet C. M.","display":"Vissers, Margreet C. M.","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Royds, Janice A.","roleDisplay":"VerfasserIn","role":"aut","family":"Royds","given":"Janice A."},{"given":"Tania L.","family":"Slatter","role":"aut","roleDisplay":"VerfasserIn","display":"Slatter, Tania L."},{"given":"Gabi U.","family":"Dachs","role":"aut","roleDisplay":"VerfasserIn","display":"Dachs, Gabi U."},{"roleDisplay":"VerfasserIn","display":"Phillips, Elisabeth","role":"aut","family":"Phillips","given":"Elisabeth"}],"title":[{"title_sort":"Iron content of glioblastoma tumours and role of ferrous iron in the hypoxic response in vitro","title":"Iron content of glioblastoma tumours and role of ferrous iron in the hypoxic response in vitro"}],"physDesc":[{"extent":"12 S.","noteIll":"Illustrationen"}],"relHost":[{"part":{"pages":"1-12","year":"2025","extent":"12","text":"15(2025), Seite 1-12","volume":"15"},"pubHistory":["2011 -"],"recId":"684965518","language":["eng"],"note":["Gesehen am 07.11.13"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Iron content of glioblastoma tumours and role of ferrous iron in the hypoxic response in vitroFrontiers in oncology","title":[{"title_sort":"Frontiers in oncology","title":"Frontiers in oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2649216-7"],"eki":["684965518"],"issn":["2234-943X"]},"origin":[{"dateIssuedDisp":"2011-","dateIssuedKey":"2011","publisher":"Frontiers Media","publisherPlace":"Lausanne"}]}],"name":{"displayForm":["Citra Praditi, Eira Beverley-Stone, Malcolm Reid, Eleanor R. Burgess, Rebekah L. Crake, Margreet C. M. Vissers, Janice A. Royds, Tania L. Slatter, Gabi U. Dachs and Elisabeth Phillips"]},"origin":[{"dateIssuedDisp":"07 March 2025","dateIssuedKey":"2025"}],"id":{"doi":["10.3389/fonc.2025.1536549"],"eki":["1929682530"]}} 
SRT |a PRADITICITIRONCONTEN0720